Drug lookup | Fillwise

MULTIVITAMINS

All products: not a benefit

Pregnancy Multivitamin · DIN 02535718 · · tablet

Off-Formulary Interchangeable, not an ODB benefitDormant since 2026-08-03 · checked 2026-09-02 · What does dormant mean?

StatusOff-Formulary Interchangeable, not an ODB benefit

Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives

Patient paysPatient pays: program not supplied; amount cannot be determined.

Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.

1 brand, same coverage

Pregnancy Multivitamin · DIN 02535718 Manufacturer: Jamp Pharma Corporation; listing date 2025-02-28 Health Canada: Dormant since 2026-08-03 · brand PREGNANCY MULTIVITAMIN · ATC B03AE04 IRON, MULTIVITAMINS AND MINERALS · form Tablet · route Oral · ingredients FOLIC ACID 1.1 MG, VITAMIN B12 (CYANOCOBALAMIN) 12 MCG, BETA-CAROTENE 1.6 MG, NICOTINAMIDE 20 MG, D-PANTOTHENIC ACID (CALCIUM PANTOTHENATE) 5 MG, CALCIUM (CALCIUM CARBONATE) 300 MG, IODINE (POTASSIUM IODIDE) 0.15 MG, VITAMIN B2 (RIBOFLAVIN) 3.4 MG, ASCORBIC ACID (ASCORBIC ACID) 120 MG, VITAMIN B1 (THIAMINE MONONITRATE) 3 MG, MAGNESIUM (MAGNESIUM OXIDE) 50 MG, IRON (FERROUS FUMARATE) 35 MG, ZINC (ZINC OXIDE) 15 MG, COPPER (COPPER GLUCONATE) 2 MG, VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) 13.8 MG, VITAMIN D3 (CHOLECALCIFEROL) 600 UNIT, VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) 10 MG · company Jamp pharma corporation · schedule Prescription

Check this DIN again · Health Canada product record

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=102454 · Verify on the e-Formulary ↗ (DIN 02535718)

Source record

DIN 02535718: Pregnancy Multivitamin Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 882800066; group id 889; item number 2135; lccId None; manufacturer id JPC Source form: Tab; strength: None Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $0.3125; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02535718 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=102454

Interchangeable products

Pregvit · DIN 02451573 · not recorded

Shortage status: resolved shortage (ended 2026-07-31); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02535718

Shortage record checked 2026-09-13T08:10:21.292534+00:00

Health Canada lists this DIN as Dormant since 2026-08-03 — choose a marketed DIN from the same-category list.

Pregnancy Multivitamin Folic 5 · DIN 02537478 · · tablet

Off-Formulary Interchangeable, not an ODB benefitDormant since 2026-08-03 · checked 2026-09-02

StatusOff-Formulary Interchangeable, not an ODB benefit

Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives

Patient paysPatient pays: program not supplied; amount cannot be determined.

Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.

1 brand, same coverage

Pregnancy Multivitamin Folic 5 · DIN 02537478 Manufacturer: Jamp Pharma Corporation; listing date 2025-02-28 Health Canada: Dormant since 2026-08-03 · brand PREGNANCY MULTIVITAMIN FOLIC 5 · ATC B03AE04 IRON, MULTIVITAMINS AND MINERALS · form Tablet · route Oral · ingredients COPPER (COPPER GLUCONATE) 2 MG, CALCIUM (CALCIUM CARBONATE) 300 MG, VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) 10 MG, IRON (FERROUS FUMARATE) 35 MG, IODINE (POTASSIUM IODIDE) 0.15 MG, VITAMIN B2 (RIBOFLAVIN) 3.4 MG, VITAMIN B1 (THIAMINE MONONITRATE) 3 MG, MAGNESIUM (MAGNESIUM OXIDE) 50 MG, VITAMIN B12 (CYANOCOBALAMIN) 12 MCG, D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE) 5 MG, VITAMIN D3 (CHOLECALCIFEROL) 600 UNIT, NICOTINAMIDE 20 MG, FOLIC ACID 5 MG, ASCORBIC ACID 120 MG, BETA-CAROTENE 1.6 MG, VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) 13.8 MG, ZINC (ZINC OXIDE) 15 MG · company Jamp pharma corporation · schedule Prescription

Check this DIN again · Health Canada product record

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=102618 · Verify on the e-Formulary ↗ (DIN 02537478)

Source record

DIN 02537478: Pregnancy Multivitamin Folic 5 Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 882800067; group id 889; item number 2136; lccId None; manufacturer id JPC Source form: Tab; strength: None Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $0.5025; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02537478 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=102618

Interchangeable products

Pregvit Folic 5 · DIN 02451581 · not recorded

Shortage status: resolved shortage (ended 2026-07-31); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02537478

Shortage record checked 2026-09-13T08:10:21.292534+00:00

Health Canada lists this DIN as Dormant since 2026-08-03 — choose a marketed DIN from the same-category list.

Pregvit · DIN 02451573 · · tablet

Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2025-03-07 — choose a marketed DIN from the same-category list.Discontinued 2025-03-07 · checked 2026-09-02

StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2025-03-07 — choose a marketed DIN from the same-category list.

Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2025-03-07 — choose a marketed DIN from the same-category list.

Patient paysPatient pays: program not supplied; amount cannot be determined.

Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.

1 brand, same coverage

Pregvit · DIN 02451573 Manufacturer: Duchesnay Inc.; listing date 2025-02-28 Health Canada: Cancelled post market since 2025-03-07 · brand PREGVIT · ATC B03AE04 IRON, MULTIVITAMINS AND MINERALS · form Tablet · route Oral · ingredients ASCORBIC ACID (ASCORBIC ACID) 120 MG, VITAMIN D3 (CHOLECALCIFEROL) 600 UNIT, BETA-CAROTENE 1.6 MG, NICOTINAMIDE 20 MG, FOLIC ACID 1.1 MG, VITAMIN B1 (THIAMINE MONONITRATE) 3 MG, ZINC (ZINC OXIDE) 15 MG, VITAMIN B12 (CYANOCOBALAMIN) 12 MCG, MAGNESIUM (MAGNESIUM OXIDE) 50 MG, VITAMIN B2 (RIBOFLAVIN) 3.4 MG, VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) 10 MG, VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) 13.8 MG, COPPER (CUPRIC OXIDE) 2 MG, D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE) 5 MG, IRON (FERROUS FUMARATE) 35 MG, CALCIUM (CALCIUM CARBONATE) 300 MG, IODINE (POTASSIUM IODIDE) 0.15 MG · company Duchesnay inc · schedule Prescription

Check this DIN again · Health Canada product record

Pregvit: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=93788 · Verify on the e-Formulary ↗ (DIN 02451573)

Source record

DIN 02451573: Pregvit Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 882800066; group id 889; item number 2135; lccId None; manufacturer id DUI Source form: Tab; strength: None Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02451573 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=93788

Interchangeable products

Pregnancy Multivitamin · DIN 02535718 · not recorded

Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02451573

Shortage record checked 2026-09-13T08:10:21.292534+00:00

Health Canada lists this DIN as Cancelled post market since 2025-03-07 — choose a marketed DIN from the same-category list.

Pregvit Folic 5 · DIN 02451581 · · tablet

Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2025-03-31 — choose a marketed DIN from the same-category list.Discontinued 2025-03-31 · checked 2026-09-02

StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2025-03-31 — choose a marketed DIN from the same-category list.

Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2025-03-31 — choose a marketed DIN from the same-category list.

Patient paysPatient pays: program not supplied; amount cannot be determined.

Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.

1 brand, same coverage

Pregvit Folic 5 · DIN 02451581 Manufacturer: Duchesnay Inc.; listing date 2025-02-28 Health Canada: Cancelled post market since 2025-03-31 · brand PREGVIT FOLIC 5 · ATC B03AE04 IRON, MULTIVITAMINS AND MINERALS · form Tablet · route Oral · ingredients FOLIC ACID 5 MG, VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) 13.8 MG, ASCORBIC ACID (ASCORBIC ACID) 120 MG, MAGNESIUM (MAGNESIUM OXIDE) 50 MG, VITAMIN D3 (CHOLECALCIFEROL) 600 UNIT, IRON (FERROUS FUMARATE) 35 MG, BETA-CAROTENE 1.6 MG, NICOTINAMIDE 20 MG, IODINE (POTASSIUM IODIDE) 0.15 MG, CALCIUM (CALCIUM CARBONATE) 300 MG, D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE) 5 MG, VITAMIN B2 (RIBOFLAVIN) 3.4 MG, VITAMIN B12 (CYANOCOBALAMIN) 12 MCG, VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) 10 MG, COPPER (CUPRIC OXIDE) 2 MG, VITAMIN B1 (THIAMINE MONONITRATE) 3 MG, ZINC (ZINC OXIDE) 15 MG · company Duchesnay inc · schedule Prescription

Check this DIN again · Health Canada product record

Pregvit Folic 5: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=93789 · Verify on the e-Formulary ↗ (DIN 02451581)

Source record

DIN 02451581: Pregvit Folic 5 Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 882800067; group id 889; item number 2136; lccId None; manufacturer id DUI Source form: Tab; strength: None Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02451581 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=93789

Interchangeable products

Pregnancy Multivitamin Folic 5 · DIN 02537478 · not recorded

Shortage record checked 2026-09-13T08:10:21.292534+00:00

Health Canada lists this DIN as Cancelled post market since 2025-03-31 — choose a marketed DIN from the same-category list.

MULTIVITAMINS FOR INFUSION

All strengths: General benefit; same patient cost rules

Shared coverage and patient cost rules

StatusGeneral benefit

Patient paysPatient pays: program not supplied; amount cannot be determined.

Multi-12 · DIN 02100606 · · injection-2x5mL vial

General benefitMarketed · checked 2026-09-02

Write on scriptno code needed

Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.

No interchangeable product listed in the Ontario extract

Multi-12 · DIN 02100606 Manufacturer: Sandoz Canada Inc.; listing date 2019-04-30 Health Canada: Marketed since 2025-10-23 · brand MULTI 12 · ATC B05XC VITAMINS · form Solution · route Intravenous · ingredients VITAMIN B2 (RIBOFLAVIN-5-PHOSPHATE) 0.72 MG/ML, VITAMIN D 40 UNIT/ML, VITAMIN B12 (VITAMIN B12) 1 MCG/ML, VITAMIN B1 (THIAMINE HYDROCHLORIDE) 0.6 MG/ML, BIOTIN 12 MCG/ML, VITAMIN E 2 UNIT/ML, FOLIC ACID 80 MCG/ML, DEXPANTHENOL 3 MG/ML, ASCORBIC ACID 20 MG/ML, PYRIDOXINE HYDROCHLORIDE 0.8 MG/ML, NICOTINAMIDE 8 MG/ML, VITAMIN A 660 UNIT/ML · company Sandoz canada incorporated · schedule Ethical

Check this DIN again · Health Canada product record

Multi-12: Formulary list price $23.0000/unit (unit not stated in source; not the patient's cost)

Ministry pays: $23.0000 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=16462 · Verify on the e-Formulary ↗ (DIN 02100606)

Source record

DIN 02100606: Multi-12 Raw flags: sec3=Y Item: 882800041; group id 890; item number 2137; lccId None; manufacturer id SDZ Source form: Inj-2x5mL Vial Pk; strength: None Recorded listing: General benefit Source prices (unrounded): $23.0000; ministry $23.0000 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02100606 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=16462

Shortage status: active shortage (reported 2026-05-29, last updated 2026-06-04); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02100606

Shortage record checked 2026-09-13T08:10:21.292534+00:00

Multi 12/K1 Pediatric · DIN 02242529 · · injection-4mL+1mL vial

General benefitMarketed · checked 2026-09-02

Write on scriptno code needed

Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.

No interchangeable product listed in the Ontario extract

Multi 12/K1 Pediatric · DIN 02242529 Manufacturer: Sandoz Canada Inc.; listing date 2019-04-30 Health Canada: Marketed since 2006-07-06 · brand MULTI-12/K1 PEDIATRIC · ATC B05XC VITAMINS · form Solution · route Intravenous · ingredients PYRIDOXINE HYDROCHLORIDE 1 MG/VIAL, VITAMIN A 2300 UNIT/VIAL, VITAMIN K1 0.2 MG/VIAL, VITAMIN D 400 UNIT/VIAL, ASCORBIC ACID (ASCORBIC ACID) 80 MG/VIAL, VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) 7 UNIT/VIAL, VITAMIN B12 (CYANOCOBALAMIN) 1 MCG/VIAL, VITAMIN B1 (THIAMINE HYDROCHLORIDE) 1.2 MG/VIAL, VITAMIN B2 (RIBOFLAVIN-5-PHOSPHATE) 1.4 MG/VIAL, DEXPANTHENOL 5 MG/VIAL, BIOTIN 20 MCG/VIAL, NICOTINAMIDE 17 MG/VIAL, FOLIC ACID 140 MCG/VIAL · company Sandoz canada incorporated · schedule Prescription

Check this DIN again · Health Canada product record

Multi 12/K1 Pediatric: Formulary list price $41.8000/unit (unit not stated in source; not the patient's cost)

Ministry pays: $41.8000 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66277 · Verify on the e-Formulary ↗ (DIN 02242529)

Source record

DIN 02242529: Multi 12/K1 Pediatric Raw flags: sec3=Y Item: 882800056; group id 890; item number 2138; lccId None; manufacturer id SDZ Source form: Inj-4mL+1mL Vial Pk; strength: None Recorded listing: General benefit Source prices (unrounded): $41.8000; ministry $41.8000 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02242529 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66277

Shortage status: resolved shortage (ended 2024-02-05); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02242529

Shortage record checked 2026-09-13T08:10:21.292534+00:00

Other drugs in the same formulary class (88:28 Multivitamins) and how they are covered

No products matched this class search: “88:28”. This is a search result, not a decision about coverage. Try a different class name, abbreviation or class code. Search this as a medication name or DIN

Full class listing Related classes: 88:08 Vitamin B, 88:12 Vitamin C, 88:16 Vitamin D Same formulary class, not same indication: class membership alone does not establish equivalent uses.

What the Health Canada label says it is for

Product monograph unavailable: no marketed product found

What the Health Canada label says it is for

INDICATIONS AND CLINICAL USE Multi-12® is indicated for use as a supplement to parenteral nutrition for adults and children aged 11 and above. Its administration helps to maintain plasma vitamin levels and helps to prevent depletion of endogenous stores of the vitamins and development of subsequent deficiency symptoms. It is also indicated where there are increased requirements for vitamins due to stress situations such as surgery, extensive burns, fractures and other trauma, severe infectious diseases, and comatose states. Vitamin therapy should be initiated before development of clinical signs of vitamin deficiency. Patients with multiple vitamin deficiencies or with markedly increased requirements may be given multiples of the daily dosage for two or more days as indicated by the clinical status. https://pdf.hres.ca/dpd_pm/00082180.PDF PM date: OCT 23, 2025 Source product: MULTI 12; DIN 02100606; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.

Availability

Multi-12 · DIN 02100606 Shortage status: active shortage (reported 2026-05-29, last updated 2026-06-04); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02100606

Check this DIN again

Health Canada: dormant products

Health Canada defines dormant products as: “products that were previously marketed in Canada but for which the manufacturer has suspended sale for period of at least 12 months.” (canada.ca, Sep 10, 2026 ↗)

Other review policies

For Pregnancy Multivitamin, Pregnancy Multivitamin Folic 5, Pregvit, Pregvit Folic 5: no applicable EAP criteria are held and no ODB benefit is established. These policies do not establish coverage.

For rare, immediately life-, limb- or organ-threatening circumstances, the Compassionate Review Policy may consider an unfunded drug or indication, subject to its criteria and without bypassing the drug review process. Compassionate Review Policy

Compassionate Review Policy: source quote

Where there are rare clinical circumstances in immediately life, limb, or organ-threatening conditions, the Executive Officer will also consider requests for drugs or indications in situations where there has not been a decision by the Executive Officer to provide funding of the drug or indication as part of the Ontario Drug Benefit program (and the EAP), and the drug or indication requested would not circumvent the established review process for new drugs or indications as part of the drug submission process for listing within the Ontario Drug Benefit program. Requests must meet the criteria for the Compassionate Review Policy.

Ontario source; updated September 15, 2026

For cancer drugs, Case-by-Case Review considers rare, immediately life-threatening circumstances when no satisfactory funded treatment exists; its criteria and application process apply. Case-by-Case Review (cancer drugs)

Case-by-Case Review (cancer drugs): source quote

Note: Requests for cancer drugs are considered under the Case-by-Case Review Program (CBCRP) which is administered by Ontario Health (Cancer Care Ontario) on behalf of the Ministry of Health. The CBCRP considers funding requests for drugs (both oral therapies and injectable drugs) for the treatment of cancer in patients who have a rare clinical circumstance that is immediately life-threatening (death is likely within a matter of months) and who require treatment with an unfunded drug, because there is no other satisfactory and funded treatment. Please refer to the Ontario Health website for information on the application process, FAQs, eligibility criteria and program policies.

Ontario source; updated September 15, 2026